327 related articles for article (PubMed ID: 21156754)
1. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
Feng W; Barrientos GC; Cherednichenko G; Yang T; Padilla IT; Truong K; Allen PD; Lopez JR; Pessah IN
Mol Pharmacol; 2011 Mar; 79(3):420-31. PubMed ID: 21156754
[TBL] [Abstract][Full Text] [Related]
2. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.
Barrientos GC; Feng W; Truong K; Matthaei KI; Yang T; Allen PD; Lopez JR; Pessah IN
J Biol Chem; 2012 Jan; 287(4):2863-76. PubMed ID: 22139840
[TBL] [Abstract][Full Text] [Related]
3. A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels.
Bannister RA; Estève E; Eltit JM; Pessah IN; Allen PD; López JR; Beam KG
J Gen Physiol; 2010 Jun; 135(6):629-40. PubMed ID: 20479108
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
[TBL] [Abstract][Full Text] [Related]
5. A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.
Estève E; Eltit JM; Bannister RA; Liu K; Pessah IN; Beam KG; Allen PD; López JR
J Gen Physiol; 2010 Jun; 135(6):619-28. PubMed ID: 20479110
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.
Truong KM; Pessah IN
Toxicol Sci; 2019 Feb; 167(2):509-523. PubMed ID: 30329129
[TBL] [Abstract][Full Text] [Related]
7. Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.
Giulivi C; Ross-Inta C; Omanska-Klusek A; Napoli E; Sakaguchi D; Barrientos G; Allen PD; Pessah IN
J Biol Chem; 2011 Jan; 286(1):99-113. PubMed ID: 20978128
[TBL] [Abstract][Full Text] [Related]
8. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
[TBL] [Abstract][Full Text] [Related]
9. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
10. Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.
Lefebvre R; Legrand C; Groom L; Dirksen RT; Jacquemond V
PLoS One; 2013; 8(1):e54042. PubMed ID: 23308296
[TBL] [Abstract][Full Text] [Related]
11. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Ta TA; Pessah IN
Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
[TBL] [Abstract][Full Text] [Related]
12. Ablation of skeletal muscle triadin impairs FKBP12/RyR1 channel interactions essential for maintaining resting cytoplasmic Ca2+.
Eltit JM; Feng W; Lopez JR; Padilla IT; Pessah IN; Molinski TF; Fruen BR; Allen PD; Perez CF
J Biol Chem; 2010 Dec; 285(49):38453-62. PubMed ID: 20926377
[TBL] [Abstract][Full Text] [Related]
13. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.
Eltit JM; Ding X; Pessah IN; Allen PD; Lopez JR
FASEB J; 2013 Mar; 27(3):991-1000. PubMed ID: 23159934
[TBL] [Abstract][Full Text] [Related]
15. A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
Andronache Z; Hamilton SL; Dirksen RT; Melzer W
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4531-6. PubMed ID: 19246389
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.
Vega AV; Ramos-Mondragón R; Calderón-Rivera A; Zarain-Herzberg A; Avila G
J Physiol; 2011 Oct; 589(Pt 19):4649-69. PubMed ID: 21825032
[TBL] [Abstract][Full Text] [Related]
17. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.
Diaz-Sylvester PL; Porta M; Copello JA
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1103-12. PubMed ID: 18305228
[TBL] [Abstract][Full Text] [Related]
18. T lymphocytes from malignant hyperthermia-susceptible mice display aberrations in intracellular calcium signaling and mitochondrial function.
Yang L; Dedkova EN; Allen PD; Jafri MS; Fomina AF
Cell Calcium; 2021 Jan; 93():102325. PubMed ID: 33310301
[TBL] [Abstract][Full Text] [Related]
19. Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice.
Aleman M; Zhang R; Feng W; Qi L; Lopez JR; Crowe C; Dong Y; Cherednichenko G; Pessah IN
Mol Pharmacol; 2020 Oct; 98(4):351-363. PubMed ID: 32764093
[TBL] [Abstract][Full Text] [Related]
20. Impaired interaction between skeletal ryanodine receptors in malignant hyperthermia.
Liang X; Chen K; Fruen B; Hu J; Ma J; Hu X; Parness J
Integr Biol (Camb); 2009 Sep; 1(8-9):533-9. PubMed ID: 20023768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
